On February 18, 2026, a significant crackdown by the Federal Investigation Agency (FIA) in Karachi led to the discovery of a factory producing counterfeit cancer medications. The operation, conducted in the suburban area of Ahsanabad, resulted in the seizure of a large quantity of unregistered and potentially lethal drugs. According to Express News, the factory was found manufacturing pain relief medication intended for cancer patients in doses of 225 mg, far exceeding the legal limit of 50 mg. This poses severe health risks, as the counterfeit drugs have been reportedly supplied through illegal channels not only within Pakistan but also to other countries. The FIA's sources indicated that the value of the seized raw materials and machinery amounts to millions of rupees, and multiple arrests were made during the operation, with more expected to follow. "The operation was crucial in preventing these dangerous drugs from reaching vulnerable patients," an FIA spokesperson stated.